Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Visual field defect
ADR ID BADD_A04594
ADR Hierarchy
06      Eye disorders
06.02      Vision disorders
06.02.07      Visual field disorders
06.02.07.003      Visual field defect
17      Nervous system disorders
17.17      Neurological disorders of the eye
17.17.01      Neurologic visual problems NEC
17.17.01.001      Visual field defect
Description A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES (e.g., RETINAL DISEASES and GLAUCOMA); OPTIC NERVE DISEASES, and other conditions. | A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES (e.g., RETINAL DISEASES and GLAUCOMA), OPTIC NERVE DISEASES, and other conditions. [MeSH]
MedDRA Code 10047555
MeSH ID D012607
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Arcuate scotoma | Blind spot enlarged | Central scotoma | Defect visual field (NOS) | Generalized visual field contraction or constriction | Mariotte's spot enlarged | Other localized visual field defect | Peripheral vision defective | Scotoma | Scotoma annular | Scotoma central | Scotoma involving central area | Scotoma of blind spot area | Scotoma peripheral | Scotoma transient | Sector or arcuate visual field defects | Vision central defective | Vision peripheral decreased | Vision peripheral defective | Visual field constriction | Visual field defect | Visual field defect NOS | Visual field defect, unspecified | Visual field defects | Bilateral visual field constriction | Scotomas | Scotoma, Arcuate | Arcuate Scotoma | Arcuate Scotomas | Scotomas, Arcuate | Scotoma, Bjerrum | Bjerrum Scotoma | Bjerrum Scotomas | Scotomas, Bjerrum | Scotoma, Central | Central Scotoma | Central Scotomas | Scotomas, Central | Scotoma, Sector | Scotomas, Sector | Sector Scotoma | Sector Scotomas | Scotoma, Paracecal | Paracecal Scotoma | Paracecal Scotomas | Scotomas, Paracecal | Scotoma, Paracentral | Paracentral Scotoma | Paracentral Scotomas | Scotomas, Paracentral | Scotoma, Peripheral | Peripheral Scotoma | Peripheral Scotomas | Scotomas, Peripheral | Scotoma, Ring | Ring Scotoma | Ring Scotomas | Scotomas, Ring | Scotoma, Scintillating | Scintillating Scotoma | Scintillating Scotomas | Scotomas, Scintillating | Scotoma, Altitudinal | Altitudinal Scotoma | Altitudinal Scotomas | Scotomas, Altitudinal | Scotoma, Centrocecal | Centrocecal Scotoma | Centrocecal Scotomas | Scotomas, Centrocecal
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01894Quinidine sulfate--
BADD_D01895Quinine--
BADD_D01896Quinine dihydrochloride--
BADD_D01897Quinine sulfate--
BADD_D01916Rasagiline mesylate--
BADD_D01933Ribavirin--
BADD_D01936Rifampicin0.006346%
BADD_D01946Rimexolone--
BADD_D01951Risperidone0.000242%
BADD_D01952Ritonavir--
BADD_D01954Rivaroxaban--
BADD_D01966Ropinirole--
BADD_D02002Selegiline--
BADD_D02010Sertraline0.000079%
BADD_D02011Sertraline hydrochloride--
BADD_D02018Sildenafil0.001364%
BADD_D02047Sodium oxybate0.000402%
BADD_D02055Somatropin--
BADD_D02058Sorafenib0.000168%
BADD_D02098Sumatriptan0.000083%
BADD_D02104Tacrine hydrochloride--
BADD_D02106Tadalafil0.000390%
BADD_D02150Temozolomide0.000224%
BADD_D02160Terbinafine--
BADD_D02161Terbinafine hydrochloride--
BADD_D02165Teriflunomide0.000603%
BADD_D02171Testosterone cypionate0.001573%
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02219Timolol0.000100%
The 6th Page    First    Pre   6 7 8    Next   Last    Total 8 Pages